Cytidine → 4-amino-1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
반응식
[C@@H:1]1([N:10]2[CH:15]=[CH:14][C:13]([NH2:16])=[N:12][C:11]2=[O:17])[O:7][C@H:6]([CH2:8][OH:9])[C@@H:4]([OH:5])[C@H:2]1[OH:3].[OH-].[K+]>CO>[C@H:1]1([N:10]2[CH:15]=[CH:14][C:13]([NH2:16])=[N:12][C:11]2=[O:17])[O:7][C@H:6]([CH2:8][OH:9])[C@@H:4]([OH:5])[C@H:2]1[OH:3]참가 물질
4
실험 절차
The process of claim 27 wherein 1-(β-D-ribofuranosyl)-4-aminopyrimidin-2-one is contacted with potassium hydroxide in methanol to form 1-(α-D-ribofuranosyl)-4-aminopyrimidin-2-one
출처 및 근거
- ORD 기록
- ord-12b6769bb04b422a8e38d1043b6f9c35
- 출처 데이터셋
- uspto-grants-1995_05
- 특허 번호
- US05420266
반응 노트
불러오는 중…